QuidelOrtho stock falls 11% on Savanna PVP4+ assay update

seekingalpha04-03

QuidelOrtho (NASDAQ:QDEL) stock dropped 11% in afternoon trading Tuesday after the medtech company said it has pulled the FDA market application for its Savanna RVP4+ assay due to data concerns. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2424078556?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1387472103/image_1387472103.jpg","is_english":true,"pubTime":"2024-04-03 02:01","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2424078556","market":"hk","top_or_hot":-1,"title":"QuidelOrtho stock falls 11% on Savanna PVP4+ assay update","media":"seekingalpha","content":"<div>\n<p>QuidelOrtho (NASDAQ:QDEL) stock dropped 11% in afternoon trading Tuesday after the medtech company said it has pulled the FDA market application for its Savanna RVP4+ assay due to data concerns.  ...</p>\n\n<a href=\"https://seekingalpha.com/news/4086530-quidelortho-stock-falls-on-savanna-pvp4-assay-update\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QuidelOrtho stock falls 11% on Savanna PVP4+ assay update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuidelOrtho stock falls 11% on Savanna PVP4+ assay update\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-03 02:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4086530-quidelortho-stock-falls-on-savanna-pvp4-assay-update><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>QuidelOrtho (NASDAQ:QDEL) stock dropped 11% in afternoon trading Tuesday after the medtech company said it has pulled the FDA market application for its Savanna RVP4+ assay due to data concerns.  ...</p>\n\n<a href=\"https://seekingalpha.com/news/4086530-quidelortho-stock-falls-on-savanna-pvp4-assay-update\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://seekingalpha.com/news/4086530-quidelortho-stock-falls-on-savanna-pvp4-assay-update","article_id":"2424078556","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1387472103/image_1387472103.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2424078556","pubTimestamp":1712080872,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"QuidelOrtho (NASDAQ:QDEL) stock dropped 11% in afternoon trading Tuesday after the medtech company said it has pulled the FDA market application for its Savanna RVP4+ assay due to data concerns.  Quid","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","QDEL":"窥得儿医药","BK4139":"生物科技","BK4198":"医疗保健用品","MLYS":"Mineralys Therapeutics, Inc."},"translate_title":"稀树草原PVP4+检测更新导致QuidelOrtho股票下跌11%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MLYS":1,"QDEL":1},"content_text":"QuidelOrtho (NASDAQ:QDEL) stock dropped 11% in afternoon trading Tuesday after the medtech company said it has pulled the FDA market application for its Savanna RVP4+ assay due to data concerns.  QuidelOrtho said in a statement Tuesday that while earlier data for the assay had shown “great promise,” the final dataset “did not meet our expectations.” The company added that it has been working on a next-generation RVP4+ assay, which it expects to be commercially available during the 2024/2025 respiratory season.  The company also said it was making “good progress” on a sexually transmitted infection panel for the Savanna platform, with clinical trials expected to begin in Q2. RBC Capital said in a note Tuesday that QuidelOrtho was not updating its 2024 guidance for Savanna, which is $30M to $50M in 2024 with dilutive EBITDA margins. The investment bank added that it was not changing its investment thesis or price target on the stock. RBC currently has an outperform rating on QuidelOrtho, with a price target of $81. Also on Tuesday, QuidelOrtho announced it received FDA clearance for its QuickVue COVID-19 test.  More on Mineralys Therapeutics, Quidel, etc.  Mineralys Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation Mineralys Therapeutics, Inc. (MLYS) Q4 2023 Earnings Call Transcript Mineralys Therapeutics: A Story To Keep An Eye On Mineralys Therapeutics GAAP EPS of -$0.61 beats by $0.21 UBS cuts QuidelOrtho to sell, cites potential downside to estimates","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2424078556"}